The 2nd Annual World Preclinical Congress (WPC 2017) covers topics such as:
- Humanized Mouse Models: Technology and Applications in Preclinical Assessment of Cancer Immunotherapy
- New Technologies for Improving Drug Safety Screening
- Patient-Derived Organoid for Drug Development and Screening
- Immuno-Oncology Treatment with PK/PD Modelling
- The Role of Drug Transporters in Drug Research and Development
The 2nd Annual World Preclinical Congress (WPC 2017) short courses include:
- Pathology in Cancer Drug Development
- Computational Tools for Predicting Toxicity
- Mechanistic Insights Into Cardiotoxicity
- Recent Developments in Ion Channel Assays for Safety Screening
- Safety Concerns for Biological Drugs
- Use of Stem Cells for Safety Screening
- Patient Derived Cancer Tissue Xenograft Models
- Translating Biomarkers from the Lab to the Clinic
- Mechanistic Insights Into Hepatotoxicity
- Animal Models of Pain: Progress and Challenges
- Molecular Imaging in Drug Discovery and Development
